COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health.
Stephanie A RichardNusrat J EpsiDavid A LindholmAllison M W MalloyRyan C MavesCatherine M BerjohnTahaniyat LalaniAlfred G SmithRupal M ModyAnuradha GanesanNikhil HuprikarRhonda E ColomboChristopher J ColomboCristian MadarMilissa U JonesDerek T LarsonEvan C EwersSamantha BazanAnthony C FriesCarlos J MaldonadoMark P SimonsJulia S RozmanLiana AndronescuKatrin MendeDavid R TribbleBrian K AganTimothy H BurgessSimon D PollettJohn H Powersnull nullPublished in: Open forum infectious diseases (2022)
Full SARS-CoV-2 vaccination is associated with decreased severity of patient-reported symptoms across multiple domains, which in turn is likely to be associated with earlier return to usual activities. In addition, infection with the Delta variant was associated with higher FLU-PRO Plus scores than previous variants, even after controlling for vaccination status.